Somatic mutations in JAK2, MPL, and CALR are referred as “driver mutations” on the basis of their role in driving the MPN clinical phenotype and are crucial for the diagnosis along with selected laboratory and histopathological features. Here, MPL is linked to myeloproliferative neoplasm.